Multiple roles of ATP and adenosine in somatosensory processing: Therapeutic implications

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 279-288

  Keil II, Gary J ^a   Salter, Michael W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adenosine; ATP; Somatoscnsory processing

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE;

ANALGESIA; CONFERENCE PAPER; HUMAN; NEUROTRANSMISSION; NONHUMAN; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN;

EID: 0030437881     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<279::AID-DDR7>3.0.CO;2-O     Document Type: Conference Paper

References (112)

1. Aley KO, Green PG, Levine JD (1995): Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci 15:8031-8038.
2. Bean BP (1990): ATP-activated channels in rat and bullfrog sensory neurones. Concentration dependence and kinetics. J Neurosci 10:1-10.
3. Belfrage M, Sollevi A, Segerdahl M, Sjölund K-F, Hansson P (1995): Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 8:713-717.
4. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D (1987): Cardiovascular and respiratory effects of adenosine in conscions man. Evidence for carotid body chemoreceptor activation. Circ Res 61:779-786.
5. Bleehen T, Keele CA (1977): Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 3:367-377.
6. Burnstock G (1978): A basis for distinguishing two types of purinergic receptor. In Straub RW. Bolis L (eds): Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York: Rave Press, pp 107-118.
7. Burnstock G (1990): Pnrinergic mechanisms. Ann NY Acad Sci 603:1-17.
8. 2+ channels to release adenosine from spinal cord synaptosomes. J Neurochem 60:894-901.
9. Cahill CM, White TD, Sawynok J (1995): Spinal opioid receptors and adenosine release: Neurochemical and behavioural characterization of opioid subtypes. J Pharmacol Exp Ther 275:84-93.
10. Chen C-C, Akoplan AN, Sivilotti L, Colqnhoun D, Burnstock G, Wood JN (1995): A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377:428-431.
11. 2 adenosine receptors in the rat spinal cord. J Pharmacol Exp Ther 242:905-910.
12. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurones: An andoradiographic study. J Pharmacol Exp Ther 247:757-764.
13. Collier HOJ, Jaiws GWL, Schneider C (1966): Antagonism by aspirin and femanates of bronchoconstriction and nociception by adeuosinc-5′-triphosphate. Nature 212:411-412.
14. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495-2507.
15. Cronstein BN (1995): A novel approach to the development of antiinflammatory agents: Adenosine release at inflamed sites. J Invest Med 43:50-57
16. Cronstein BN, Naime D, Firestein GS (1995): The antiiflammatory effects of an adenosinc kinase inhibitor are mediated by adenosine. Arthritis Rheum 38:1040-1045.
17. DeKoninck Y, Henry JL (1992): Peripheral vibration causes an adenosine-mediated postsyuaptic inhibitory potential in dorsal horn neurones in the cat spinal cord. Neuroscience 50:435-143.
18. De Lander CE, Keil H GJ (1994): Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J Pharmacol Exp Ther 268:943-951.
19. DeLander GE, Mossberg III, Porreca F (1992): Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: Dissociation from gastrointestinal effects in mice. J Pharmacol Exp Ther 263:1097-1104.
20. Doak GJ, Sawynok J (1995): Complex role of peripheral adenosine in the genesis ol the response to subcutaneous formalin in the rat. Eur J Pharmacol 281:311-318.
21. Dolphin AC, Forda SR, Scott RH (1986): Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analog. J Physiol (London) 373:47-61.
22. Dray A, Urban L, Dickenson A (1994): Pharmacology of chronic pain. Trends Pharmacol Sci 15:190-197.
23. 2-purinoceptor antagonists in rats. Brain Res 666:182-188.
24. 2-purinergic receptors from extracellular ATP and other nucleotides. Am J Physiol 265 (Cell Physiol 43):C:.577-606.
25. Dubyak CR, Cowen DS, Lazarus HM (1988): Activation of the inositol phospholipid signaling system by receptors for extracellular ATP in human neutrophils, monocytes and neutrophil/inonocyte progenitor cells. Ann NY Acad Sci 551:218-237.
26. Firestein GS, Boyle D, Bullough DA, Gruber HE, Sajjadi FG, Montag A, Sambol B, Mullare KM (1994): Protective effect of an adenosine kinase inhibitor in septic shock. J Immnnol 152:5853-5859.
27. Fredholm BB (1980): Are methylxanthine efiects due to antagonism of endogenous adenosine? Trends Pharmacol Sci 1:129-132.
28. Fredholm BB, Dunwiddie TV (1988): How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134.
29. Fredholm BB, Abbracchio MP, Burnstock C, Daly JW, Harden TK, Jacobson KA, Leff R Williams M (1994): Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
30. Fyffe RE, Perl ER (1984): Is ATP a central synaptic mediator for certain primary afferent fibers from mammalian skin? Proc Natl Acad Sci 81:6890-6893.
31. Gadangi P Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC, Buckley MT, Carlin C, Cronstein BN (1996): The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 156:1937-1941.
32. Galindo A, Krnjevic K, Schwartz S (1967): Microiontophoretic studies on neurones in the cuneate nucleus. J Physiol (London) 192:359-377.
33. Garrison CJ, Dougherty PM, Kajander KG, Carlton SM (1991): Staining of GFAP in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565:1-7.
34. Geiger JD, LaBella FS, Nagy JI (1984): Characterization and localization of adenosine receptors in rat spinal cord. J Neurosci 4:2303-2310.
35. Gilmore SA, Sims TJ, Leiting JE (1990): Astrocytic reactions in spinal gray matter following sciatic axotomy. Glia 3:342-349.
36. Goldstein PA, Lee CJ, Bardoni R, Gu JG, MacDermott AB (1996): ATP-receptor mediated synaptic transmission in the dorsal horn of the rat spinal cord. Soc for Neurosci (Abs) Vol I: 788.
37. Golembiowska K, White TD, Sawynok J (1995): Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res 699:315-320.
38. Golembiowska K, White TD, Sawynok J (1996): Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur J Pharmacol 307:157-162.
39. 3H)cyclohexyladenosine. J Neurosci 2:1230-1241.
40. Gross RA, Macdonald RL, Ryan-Jastrow T (1989): 2-Chloroadenosine reduces the N calcium current of cultured mouse sensory neurones in a pertussis toxin-sensitive manner. J Physiol 411:585-595.
41. Hajos F, Csillik B, Knyihar-Csillik E (1990): Alterations in flial fibrillary acidic protein immunoreactivity in the upper dorsal horn of the rat spinal cord in the course of transganglionic degenerative atrophy and regenerative proliferation. Neurosci Lett 117:8-13.
42. Handwerker HO, Reeh PW (1991) Pain and inflammation. In Bond MR, Charlton JE, Woolf CJ (eels): Pain Research and Clinical Management. New York: Elsevier Science, pp 59-70.
43. Holton P (1959): The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol (London) 145:494-504.
44. Holton FA, Holton P (1954): The capillary dilator substances in dry powders of spinal roots: a possible role of adenosine triphospbate in chemical transmission from nerve endings. J Physiol (London) 126:124-140.
45. Illes P, Nörenberg W (1993): Neuronal ATP receptors and their mechanism of action. Trends Phannacol Sci 14:50-54.
46. Jahr CE, Jessel TM (1983): ATP excites a subpopulation of rat dorsal horn neurones. Nature 304:730-733.
47. Jessell TM, Jahr CE (1985): Fast and slow excitatory transmitters at primary afferent synapses in the dorsal horn of the spinal cord. In: Advances in Pain Research and Therapy. New York: Raven Press, pp 31-39.
48. Jurna I (1984): Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord. Arch Pharmacol 327:23-30.
49. Karlsten R, Gordh T, Hartviql, Post C (1990): Effects of intrathecal injection of the adenosine receptor agonist R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nocieption and motor function in the rat. Anesth Analg 71:60-64.
50. 1-adenosine receptor. Neurosci Lett 121:267-270.
51. Karlstein R, Gordh T, Post C (1992): Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol Toxicol 70:434-138.
52. Keil II GJ, DeLander GE (1992): Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sci 51:PL171-176.
53. Keil II GJ, DeLander GE (1994): Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine-and opioid agonist-induced antinociception in mice. Eur J Pharmaeol 271:37-16.
54. Keil II GJ, DeLander CE (1995): Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 274:1387-1392.
55. Keil II GJ, DeLander CE (1996): Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission. Eur J Pharmacol 312:7-14.
56. Krishtal OA, Marchenko SM, Pidoplichko VI (1983): Receptor for ATP in the membrane of mammalian sensory neurones. Neurosci Lett 35:41-45.
57. Lagerqvist B, Sylvén C, Beermann B, Helmins G, Waldenström A (1990): Intracoronary adenosine causes angina pectoris like pain: An inquiry into the nature of visceral pain. Cardiovasc Res 24:609-613.
58. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377:432-435.
59. Li J, Perl ER (1994): Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Neurophysiol 72:1611-1621.
60. Li J, Perl ER (1995): ATP modulation of synaptic transmission in the spinal substantia gelatinosa. J Neurosci 15:3357-3365.
61. 3 receptors: Pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:298-306.
62. Macdonald RL, Skerritt JH, Werz MA (1986): Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture. J Physiol (London) 370:75-90.
63. Malmberg AB, Yaksh TL (1993): Pharmacology of the spinal action of ketorolac, morphone, ST-91, U50,488H, and L-PlA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 79:270-281.
64. Marchand S, Li J, Charest J (1995): Effects of caffeine on analgesia from transcntaneous electrical nerve-stimulation. NEJM 333:325-326.
65. Meller ST, Dykstra C, Grzybycki D, Murphy S, Gebhart GF (1994): The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33:1471-1478.
66. 2α-induced allodynia in conscious mice. Pain Res 7:129-134.
67. 2α to conscious mice. Pain 50:223-229.
68. 3]adenosine binding sites in rat and guinea pig brain. Neuropharniacology 21:575-580.
69. Nagaoka H, Sakurada S, Sakurada T, Takeda S, Nakagawa Y, Kisara K, Arai Y (1993): Theophylline-induced nociceptive behavioral response in mice: Possible indirect interaction with spinal N-methyl-D-aspartate receptors. Neurochem Int 22:69-74.
70. Phillis JW, Kirkpatrick JR (1978): The actions of adenosine and various nuclensides and nucleotides on the isolated toad spinal cord. Gen Pharmacol 9:239-247.
71. Poon A, Sawynnk J (1995): Antinociception by adenosine analogs and ana adenosine kinase inhibitor: Dependence on formalin concentration. Eur J Pharmacol 286:177-184.
72. Rang HP Bevan S, Dray A (1991): Chemical activation of nociceptive peripheral neurones. Br Med Bull 47:534-548.
73. Reeve AJ, Dickenson AH (1995a): The roles of spinal adenosine receptors in the control of acute and more persistent nocieeptive responses of dorsal horn neurones in the anaesthetized rat. Br J Pharmacol 116:2221-2228.
74. Reeve AJ, Dickenson AH (1995b): Electrophysiological study on spinal antinociceptive interactions between adenosine and morphine in the dorsal horn of the rat. Neurosci Lett 194:81-84.
75. 1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 5:1037-1048.
76. 1 adenosine receptor expression in rats. Dev Brain Res 89:202-213.
77. 2b, adenosine receptor. Mol Endocrinol 6:1598-1604.
78. Rosengren S, Bong GW, Firestein GS (1995): Anti-inflammatory effects of an adenosine kinase inhibitor: Decreased neutrophil accumulation and vascular leakage. J Immunol 154:5444-5451.
79. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS (1996): Inhibition of TNF-α by adenosine. Role of A3 adenosine receptors. J Immunol 156:3435-3442.
80. Salt TE, Hill RG (1983): Excitation of single sensory neurones in the rat caudal trigeminal nucleus by iontophoretically applied adenosine 5′-triphosphate. Neurosci Lett 35:53-57.
81. Salter MW, Henry JL (1985): Effects of adenosine 5′-monophosphate and adenosine 5′-triphosphate on functionally identified units in the cat spinal dorsal horn. Evidence for a differential effect of adenosine 5′-triphosphate on nociceptive vs non-nociceptive units. Neuroscience 15:815-825.
82. Salter MW, Henry JL (1987): Evidence that adenosine mediates the depression of spinal dorsal horn neurones induced by peripheral vibration in the cat. Neuroscience 22:631-650.
83. Salter MW, Hicks JL (1994): ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord. J Neurosci 14:1563-1575.
84. 3 pathway in astrocytes from the dorsal spinal cord. J Neurosci 15:2961-2971.
85. + channels mediate an IPSP in dorsal horn neurones elicited by sensory stimulation. Synapse 11:214-220.
86. Salter MW, DeKoninck Y, Henry JL (1993): Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol 41:125-156.
87. Sauticioli P, Del Bianco E, Tramontana M, Maggi CA (1992): Adenosine inhibits actions potential-dependent release of calcitonin gene-related peptide-and substance P-like immimoreactivities from primary afferents in rat spinal cord. Neurosci Lett 144:211-214
88. 1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release in the rat spinal cord. Eur J Pharmacol 231:139-142.
89. Sawynok J (1991): Adenosine and pain. In Phillis JW (ed): Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Boca Raton: CRC Press, pp 391-400.
90. Sawynok J, Sweeney MI (1989): The role of purities in nociception. Neuroscience 32:557-569.
91. Sawynok J, Sweeney MI, White TD (1986): Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 88:923-930.
92. Sawynok J, Sweeney MI, White TD (1989): Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol Sci 10:186-189.
93. Sawynok J, Downie JW, Reid AR, Cahill CM, White TD (1993): ATP release from dorsal spinal cord synaptosomes: Characterization and neural origin. Brain Res 610:32-38.
94. Segerdahl M, Ekblom A, Sjölund K-F, Belfrage M, Forsberg C, Sollevi A (1995): Systemic adenosine attenuates touch evoked allosynia induced by mustard oil in humans. NeuroReport 6:753-756.
95. 2+ current of the presynaptic neuron. Proc Natl Acad Sci USA 77:1185-1189.
96. Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P (1995): Systemic adenosine infusion: A new treatment modality to alleviate neuropathic pain. Pain 61:155-158.
97. Sosnowski M, Yaksh TL (1989): Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth Analg 69:587-892.
98. 2 adenosine receptors mediating the purine antinociception, motor, and autonomie function in the rat spinal cord. J Pharmacol Exp Ther 250:915-922.
99. 2 adenosine receptor subtype. Mol Endocrine 6:384-393.
100. Stone TW (1981): Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience 6:523-555.
101. 2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18:224-229.
102. Svensson M, Eriksson P, Pesson JKE, Molander C, Arvidsson Aldskogius H (1993): The response of central glia to peripheral nerve injury. Brain Res Bull 30:499-506.
103. Sylvén C, Beermann B, Jonzon B, Brandt R (1986): Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J 293:227-230.
104. Sylvén C, Beermann B, Edlund A, Lewander R, Jonzon B, Mogensen L (1988a): Provocation of chest pain in patients with coronary insufficiency using the vasodilator adenosine. Eur Heart J 9:6-10.
105. Sylvén C, Jonzon B, Fredholm BB, Kaijer L (1988b): Adenosine injected into the brachial artery produces ischaemia-like pain or discomfort in the forearm. Cardiovasc Res 22:674-678.
106. Taiwo YO, Levine JD (1990): Direct cutaneous hyperalgesia induced by adenosine. Neurosci 38:757-762.
107. Taiwo YO, Levine JD (1991): Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44:131-135.
108. Welch SP, Dunlow LD (1993): Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: A common mechanism of action? J Pharmacol Exp Ther 267:390-399.
109. +-and veratridine-induced release of ATP from synaptosomes prepared from dorsal and ventral spinal cord. Brain Res 334:372-374.
110. Woolf CJ, Thompson JW (1994): Stimulation-induced analgesia: Transeutaneous electrical nerve stimulation (TENS) and vibration. In Wall PD, Melzack R (eds): Textbook of Pain. Edinburgh: Churchill Livingstone, pp 1191-1208.
111. Yamamoto T Yaksh TL (1993): Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunction. Life Sci 49:1955-1963.
112. Zimmermann H (1994): Signalling via ATP in the nervous system. Trends Neurosci 17:420-426.